Clinical and therapeutic features of pulmonary nontuberculous mycobacterial disease, Brazil, 1993-2011

Emerging Infectious Diseases

Volumn 19, Issue 3, 2013, Pages 393-399

  de Mello, Karla Gripp Couto ^a   Queiroz Mello, Fernanda C ^b   Borga, Liamar ^a   Rolla, Valeria ^a   Duarte, Rafael S ^b   Sampaio, Elizabeth P ^a   Holland, Steven M ^c   Prevots, D Rebecca ^c   Dalcolmo, Margareth P ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CLARITHROMYCIN; CYCLOSERINE; DOXYCYCLINE; ETHAMBUTOL; IMIPENEM; ISONIAZID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TIGECYCLINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; ATYPICAL MYCOBACTERIOSIS; BRAZIL; BRONCHIECTASIS; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; DIABETES MELLITUS; FEMALE; HEPATITIS C; HUMAN; LUNG INFECTION; MALE; MYCOBACTERIUM; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; SPUTUM ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BRAZIL; FEMALE; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; MYCOBACTERIUM KANSASII; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84874283485     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid/1903.120735     Document Type: Article

References (28)

1. Falkinham JO III. Epidemiology of infection by nontuberculous mycobacteria. Clin Microbiol Rev. 1996;9:177-215.
2. Falkinham JO III, Norton CD, LeChevallier MW. Factors influencing number of Mycobacterial avium, Mycobacterium intracellulare, and other mycobacteria in drinking water distribution systems. Appl Environ Microbiol. 2001;67:1225-31. http://dx.doi.org/10.1128/AEM.67.3.1225-1231.2001
3. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. ATS/IDSA statement: diagnosis, treatment and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367-416. http://dx.doi.org/10.1164/rccm.200604-571ST
4. Cassidy PM, Hedberg K, Saulson A, McNelly E, Winthrop KL. Nontuberculous mycobacterial disease prevalence and risk factors: a changing epidemiology. Clin Infect Dis. 2009;49:e124-9. http://dx.doi.org/10.1086/648443
5. Prevots DR, Shaw PA, Strickland D, Jackson LA, Raebel MA, Blosky MA, et al. Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivary systems. Am J Respir Crit Care Med. 2010;182:970-6. http://dx.doi.org/10.1164/rccm.201002-0310OC
6. Winthrop KL, McNelley E, Kendall B, Marshall-Olson A, Morris C, Cassidy M, et al. Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease. Am J Respir Crit Care Med. 2010;182:977-82 http://dx.doi.org/10.1164/rccm.201003-0503OC
7. Ministry of Health. Brazil. Recommendations for tuberculosis control in Brazil [in Portuguese]. Brasilia (Brazil): The Ministry; 2011.
8. Oswaldo Cruz Foundation/Ministry of Health. Brazil. MDR TB database-Helio Fraga National TB Reference Center [cited 2013 Jan 16]. http://sitetb.org/
9. Salem JI, Marôja MF, Carvalho FF, Lima MO, Feuillet A. Mycobacteria other than tubercle bacilli specimens from patients in Manaus (Amazonia, Brasil). Acta Amazon. 1989;19:139-354.
10. Leite CQF, Viana BHJ, Leite SRA, Juarez E. Incidence of Mycobacterium tuberculosis and other mycobacteria on pulmonary infections in Araraquara-SP, 1993. Rev Microbiol, São Paulo. 1995;26:101-5.
11. Chimara E, Giampaglia CMS, Martins MC, Telles MAS, Ueki SYM, Ferrazoli L. Molecular characterization of Mycobacterium kansasii isolates in the State of São Paulo between 1995-1998. Mem Inst Oswaldo Cruz. 2004;99:739-43. http://dx.doi.org/10.1590/S0074-02762004000700013
12. Pedro HSP, Pereira MIF, Goloni MRA, Ueki SYM, Chimara E. Nontuberculous mycobacteria isolated in São José do Rio Petro, Brazil between 1996 and 2005. J Bras Pneumol. 2008;34:950-5. http://dx.doi.org/10.1590/S1806-37132008001100010
13. Zamarioli LA, Coellho AGV, Pereira CM, Nascimento ACC, Ueki SYM, Chimara E. Descriptive study of the frequency of nontuberculous mycobacteria in the Baixada Santista region of the state of São Paulo, Brazil. J Bras Pneumol. 2008;34:590-4. http://dx.doi.org/10.1590/S1806-37132008000800008
14. da Costa AR, Lopes ML, Furlaneto IP, Sousa MS, Lima KVB. Molecular Identification of Nontuberculous mycobacteria isolates in a Brazilian mycobacteria reference laboratory. Diagn Microbiol Infect Dis. 2010;68:390-4. http://dx.doi.org/10.1016/j.diagmicrobio.2010.07.019
15. Matos ED, Santana MA, Santana MC, Mamede P, Bezerra BL, Panão ED, et al. Nontuberculous mycobacteria at a multiresistant tuberculosis reference center in Bahia: clinical epidemiological Aspects. Braz J Infect Dis. 2004;8:296-304. http://dx.doi.org/10.1590/S1413-86702004000400005
16. Martins AB, Lemos ACM. Infection with the Mycobacterium avium complex in patients without predisposing conditions-a case report and literature review. Braz J Infect Dis. 2005;9:173-9. http://dx.doi.org/10.1590/S1413-86702005000200009
17. Moore JE, Kruijshaar ME, Ormerod LP, Drobniewski F, Aubakar I. Increasing reports of nontuberculous mycobacteria in England, Wales and Northern Ireland. 1995-2006. BMC Public Health. 2010;10:612. http://dx.doi.org/10.1186/1471-2458-10-612
18. Guillern M, Usdin M, Arkinstall J. Tuberculosis diagnosis and drug sensitivity testing: an overview of the current diagnostic pipeline. Paris: Médecins Sans Frontières; 2006.
19. Centers for Disease Control and Prevention. Nontuberculous mycobacteria reported to the Public Health Laboratory Information System by state public health laboratories United States, 1993-1996 [cited 2013 Jan 16]. http://www.cdc.gov/tb/Laboratory_Services/NontuberculousMycobacteria.pdf.
20. O'Brien DP, Currie BJ, Krause VL. Nontuberculous mycobacterial disease in northern Australia: a case series and review of the literature. Clin Infect Dis. 2000;31:958-68. http://dx.doi.org/10.1086/318136
21. Debrunner M, Salfinger M, Brandli O, Graevenitz AV. Epidemiology and clinical significance of nontuberculous mycobacteria in patients negative for human immunodeficiency virus in Switzerland. Clin Infect Dis. 1992;15:330-45. http://dx.doi.org/10.1093/clinids/15.2.330
22. Marras TK, Daley CL. Epidemiology of human pulmonary infection with nontuberculous mycobacteria. Clin Chest Med. 2002;23:553-67. http://dx.doi.org/10.1016/S0272-5231(02)00019-9
23. Evans SA, Colville A, Evans AJ, Crisp AJ, Johnston IDA. Pulmonary Mycobacterium kansasii infection: comparison of the clinical features, treatment and outcome with pulmonary tuberculosis. Thorax. 1996;51:1248-52. http://dx.doi.org/10.1136/thx.51.12.1248
24. Barreto AMW, Campos CED. Micobactérias "não tuberculosas" no Brasil [Nontuberculous mycobacteria in Brazil]. Boletim de Pneumologia Sanitária. 2000;8;23-32.
25. Park HK, Koh WJ, Shim TS, Kwon OJ. Clinical vharacteristic and treatment outcomes of Mycobacterium kansasii lung disease in Korea. Yonsei Med J. 2010;51:552-6. http://dx.doi.org/10.3349/ymj.2010.51.4.552
26. Shitrit D, Peled N, Bishara J, Priess P, Pitlik S, Samra Z, et al. Clinical and radiological features of Mycobacterium kansasii infection and Mycobacterium simae infection. Respi Med. 2008;102:1598-603. http://dx.doi.org/10.1016/j.rmed.2008.05.004
27. Timpe A, Runyon EH. The relationship of "atypical"acid-fast bacteria to human disease. A preliminary report. J Lab Clin Med. 1954;44:202-9.
28. Kim RD, Greenberg DE, Ehrmantraut ME, Guide SV, Ding L, Shea Y, et al. Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome. Am J Respir Crit Care Med. 2008;178:1066-74. http://dx.doi.org/10.1164/rccm.200805-686OC